ALDX icon

Aldeyra Therapeutics

72 hedge funds and large institutions have $88.9M invested in Aldeyra Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $101M → $88.9M (-$12.4M)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

63% less call options, than puts

Call options by funds: $76K | Put options by funds: $207K

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$76K
Puts
$207K
Net Calls
Net Calls Change

Top Buyers

1 +$1.55M
2 +$1.32M
3 +$1.18M
4
UOC
UBS O'Connor
Illinois
+$487K
5
PM
Prosight Management
Texas
+$487K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$16.3M
2
$12.4M
3
$8.36M
4
$7.48M
5
$7.07M
6
$5.95M
7
$5.63M
8
$4.17M
9
$2.81M
10
$2.8M
11
$2.1M
12
$1.61M
13
$1.36M
14
$1.05M
15
$1.04M
16
$521K
17
$487K
18
$423K
19
$422K
20
$409K
21
$407K
22
$393K
23
$387K
24
$364K
25
$325K